Á¦ 1 Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ÅëÇÕÇÐȸ ⸳½ÉÆ÷Áö¿ò : 2021-06-27±³À°ÀÏÀÚ : 2021-06-27
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ½Å°ü2Ãþ Á¦¶ó´½È¦ ¿Ü
±³À°ÁÖÁ¦ :
Á¦ 1 Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ÅëÇÕÇÐȸ ⸳½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ
´ã´çÀÚ : ¿À»óÈ£ ±³¼ö
¿¬¶ôó : 02-2228-2080
À̸ÞÀÏ :
ODDUNG93@yuhs.ac ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í »çÀüµî·Ï: Á¤È¸¿ø(ÇǺΰú Àü¹®ÀÇ) 6¸¸¿ø, ÁØȸ¿ø(ÇǺΰú Àü°øÀÇ) 3¸¸¿ø, ¿¬±¸¿ø 5¸¸¿ø, ºñȸ¿ø 50¸¸¿ø)ÇöÀåµî·Ï: Á¤È¸¿ø(ÇǺΰú Àü¹®ÀÇ) 7¸¸¿ø, ÁØȸ¿ø (ÇǺΰú Àü°øÀÇ) 3¸¸¿ø, ¿¬±¸¿ø 6¸¸¿ø, ºñȸ¿ø 50¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-27 Á¦¶ó´½ 09:00~09:20 All about photoprotection À¯ÈÁ¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 09:20~09:40 Proper use of tranexamic acid Á¤º¸¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 09:40~10:00 Things to consider in treatment of refractory hyperpigmented disorder: Other than laser treatment ±èÇöÁ¤(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 10:00~10:20 Consensus of opinion in vitiligo treatment Á¤±âÇå(°æÈñÀÇ´ë)
ÈÞ½Ä 06-27 10:20~10:40 Coffee Break ()
±³À°½Ã°£ 06-27 Á¦¶ó´½ 10:40~11:00 Melasma pathogenesis: Focus on the dermal milieu ³ªÁ¤ÀÓ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 11:00~11:20 Treatment of refractory melasma in the real field ÃÖõÇÊ(ÇϴôÀ³¦ ÇǺΰú)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 11:20~11:40 How to handle mottled hypopigmentation laser toning ÀÌÇØ¿õ(·çÀÌ ÇǺΰú)
Åä·Ð 06-27 Á¦¶ó´½ 11:40~12:00 Panel discussion ±è¹æ¼ø ±èÀ¯Âù(SNU ÇǺΰú ¾ÆÁÖÀÇ´ë)
½Ä»ç 06-27 12:00~13:30 Á¡½É ½Ä»ç ()
±³À°½Ã°£ 06-27 Á¦¶ó´½ 13:30~14:00 Motivation of vitiligo research and its progress and future plan Àֿ̾µ(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 14:00~14:30 Cellular signaling in melanocytes ¹Ú°æÂù(À»ÁöÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 14:30~14:50 Vitiligo pathogenesis: danger within progressing melanocyte-specific autoimmunity ÀÌÈñÁ¤(Â÷ÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 14:50~15:10 Determining treatment options according to active and stable vitiligo À̽ÃÇü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 15:10~15:30 Updates in surgical treatment for stable vitiligo ¹èÁ¤¹Î(ÈúÇϿ콺ÇǺΰú)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 15:30~15:50 Upcoming targeted therapy: can JAK inhibitor be a hope for vitiligo patients? ½ÅÁ¤Çö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 15:50~16:10 Update of pigmented contact dermatitis: Multicenter study ÀÌÁ¾Èñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 16:10~16:30 Differential diagnosis of hypopigmeted diseases ÃÖÁ¾¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-27 Á¦¶ó´½ 16:30~16:50 Experiment model for the study of pigmentation and vitiligo: 3D skin containing melanocyte ½ÅÁ¤¿ì(Â÷ÀÇ´ë)
±³À°½Ã°£ 06-27 16:50~17:10 Senescence and pigmentary change ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
Åä·Ð 06-27 17:10~17:30 Wrap up discussion ÃÖ±¤¼º À̵¿À±(ÀÎÇÏÀÇ´ë ¼º±Õ°üÀÇ´ë)